Genfit

CHECK4NASH

Publishing by any means, including electronic, of documents in the nature of written articles, white pages and journals to support diagnosis or drug treatment of diseases or disorders, especially of the liver;Dissemination of documents by means of telecommunications, including electronic telecommunications, namely transmission of documents to assist in the diagnosis or treatment with medication of diseases or pathologies, particularly of the liver;CHECK FOUR NASH; CHECK FOR NASH;Business services relating to online service provision, namely collection of data and information for business purposes in the field of medical diagnostics; processing of data and information, especially in the biological, medical, diagnostic and chemical fields; collection and processing of data for business purposes particularly in the biological, medical, diagnostic and chemical sectors;Medical consultancy services in the field of metabolic disorders and liver diseases and health care consultancy services in the field of metabolic disorders and liver diseases; medical information; providing medical information; providing medical information and advice in relation to medicines, liver diseases, their diagnosis or treatment with medication;Pharmaceutical research, namely research for the discovery of new medicines; scientific research, especially in the medical, biomedical, chemical, genetic, pharmaceutical field; basic and applied scientific research; scientific research in the diagnostic field; technical scientific research; scientific research, namely, sorting and selection of molecules; scientific research services, namely development and validation of biological tests, cellular tests and genetic tests; scientific research services, namely functional genomics activities for identifying, characterizing, validating or and developing biologically active molecules; analysis of biological substances in biological fluids; computer programming in the field of scientific research and for the pharmaceutical industry; engineering services, namely surveying technical project study being scientific research; professional consultancy unrelated to business dealings in the field of scientific and medical research; research and development of new pharmaceutical products for others; scientific research in the field of pharmacy; electronic storage of data and information, especially in the biological, medical, diagnostic and chemical fields; electronic storage of data especially in the biological, medical, diagnostic and chemical sectors;

CHECK4NASH

Publishing by any means, including electronic, of documents in the nature of written articles, white pages and journals to support diagnosis or drug treatment of diseases or disorders, especially of the liver;The mark consists of the stylized wording CHECK4NASH with a design of check mark overlapping the letter K.;Dissemination of documents by means of telecommunications, including electronic telecommunications, namely transmission of documents to assist in the diagnosis or treatment with medication of diseases or pathologies, particularly of the liver;CHECK FOUR NASH; CHECK FOR NASH;Business services relating to online service provision, namely, collection of data and information for business purposes in the field of medical diagnostics; processing of data and information, especially in the biological, medical, diagnostic and chemical fields; collection and processing of data for business purposes particularly in the biological, medical, diagnostic and chemical sectors;Medical consultancy services in the field of metabolic disorders and liver diseases and health care consultancy services in the field of metabolic disorders and liver diseases; medical information; providing medical information; providing medical information and advice in relation to medicines, liver diseases, their diagnosis or treatment with medication;Pharmaceutical research, namely research for the discovery of new medicines; scientific research, especially in the medical, biomedical, chemical, genetic, pharmaceutical field; basic and applied scientific research; scientific research in the diagnostic field; technical scientific research; scientific research, namely, sorting and selection of molecules; scientific research services, namely development and validation of biological tests, cellular tests and genetic tests; scientific research services, namely functional genomics activities for identifying, characterizing, validating and developing biologically active molecules; analysis of biological substances in biological fluids; computer programming in the field of scientific research and for the pharmaceutical industry; engineering services, namely surveying technical project study being scientific research; professional consultancy unrelated to business dealings in the field of scientific and medical research; research and development of new pharmaceutical products for others; scientific research in the field of pharmacy; electronic storage of data and information, especially in the biological, medical, diagnostic and chemical fields; electronic storage of data especially in the biological, medical, diagnostic and chemical sectors;

ELATIVE

Pharmaceutical preparations for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; chemical preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; organic preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; diagnostic preparations for medical use; diagnostic reagents for medical use;Scientific research for medical purposes; pharmaceutical research and development services; conducting clinical trials for pharmaceutical products for others, in particular conducting clinical trials for determining the efficacy and safety of elafibranor; conducting clinical trials for others to determine the efficacy and safety of pharmaceutical products in the treatment of primary biliary cholangitis (PBC); conducting scientific studies and analyses in the field of pharmaceuticals and medicines; scientific research and development, namely, providing information, results and data relating to scientific or medical research and development of pharmaceutical products, via an online searchable database; conducting clinical trials for others; pharmaceutical and biological product development and research services for third parties; conducting clinical research for others; evaluation of the efficacy of pharmaceutical products; clinical product development services;

ELATIVE

The mark consists of the stylized word ELATIVE with the letters ELATI and the last letter E in blue and the letter V in orange.;Pharmaceutical preparations for the prevention and treatment of liver diseases, cholesterol diseases, metabolic diseases, gastroenterological diseases, inflammatory diseases, auto-immune diseases and cancer diseases; chemical preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholesterol diseases, metabolic diseases , gastroenterological diseases, inflammatory diseases, auto-immune diseases and cancer diseases; organic biological preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholesterol diseases, metabolic diseases , gastroenterological diseases, inflammatory diseases, auto-immune diseases and cancer diseases; diagnostic preparations for medical use; diagnostic reagents for medical use;The color(s) blue and orange is/are claimed as a feature of the mark.;Scientific research for medical purposes; pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical products, in particular conducting clinical trials for others for determining the efficacy and safety of elafibranor; conducting clinical trials for others to determine the efficacy and safety of pharmaceutical products in the treatment of primary biliary cholangitis (PBC); conducting scientific studies and analyses in the field of pharmaceuticals and medicines; scientific research and development, namely providing information, results and data relating to scientific or medical research and development of pharmaceutical products, especially from an online searchable database; medical and scientific research, namely conducting clinical trials for others; pharmaceutical and biological development and research services for third parties; clinical research for others in the field of pharmaceuticals and medicines; evaluation of the efficacy of pharmaceutical products;